Basic Information
Basic information for MIR9-3HG-222-26aa-2
Peptide Name MIR9-3HG-222-26aa-2
Genome Position chr15:89387535-89387538,89387817-89387881,89388501-89388509[+]
Species Human
Peptide Sequence MRHALESEDSEKRSRSPGGKSLKQEG
Peptide Length 26
Unique No (MIR9-3HG-204-26aa-1,MIR9-3HG-215-26aa-2,MIR9-3HG-216-26aa,MIR9-3HG-245-26aa-2)
Grand Average of Hydropathicity -1.7269
Relative Molecular Mass 3350.53
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000659235;MIR9-3HG-222
Transcript Length 4269
Coding Ability 0.5011
DNA Sequence Corresponding to Peptide ATGAGACATGCTCTGGAGTCAGAAGACAGCGAAAAGAGAAGCAGAAGCCCCGGTGGCAAGAGTCTGAAGCAGGAAGGA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :